Skip to main content

Advertisement

Table 2 Summary of the methodological quality assessment of included studies

From: Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis

Study No. References IRB approval LZD dose indicated Individualised treatment based on DST Hospital admission prior to LZD treatment DOT during treatment Treatment success definition similar to WHO
1. Abbate et al. [35] Yes Yes Yes NR NR Yes
2. Anger et al. [36] Yes Yes Yes NR Yes Yes
3. Condos et al. [37] Yes Yes Yes NR NR Yes
4. De Lorenzo et al. [38] NR Yes Yes NR NR Yes
5. Fortún et al. [39] Yes Yes Yes NR Yes Yes
6. Koh et al. [40] Yes Yes Yes NR Yes Yes
7. Koh et al. [41] Yes Yes Yes NR NR Yes
8. Lee et al. [42] Yes Yes Yes Yes Yes No
9. Liu et al. [43] NR Yes Yes Yes NR NR
10. Migliori et al. [44] Yes Yes Yes NR Yes Yes
11. Nam et al. [45] NR Yes Yes NR NR No
12. Park et al. [46] Yes Yes Yes NR NR Yes
13. Roongruangpitayakul et al. [47] Yes Yes Yes No Yes Yes
14. Schecter et al. [48] Yes Yes Yes NR Yes Yes
15. Singla et al. [49] Yes Yes Yes Yes Yes No
16. Tang et al. [50] Yes Yes Yes NR NR NR
17. Tang et al. [51] Yes Yes Yes NR Yes Yes
18. Tse-Chang et al. [52] NR Yes Yes NR NR Yes
19. Udwadia et al. [53] Yes Yes Yes No NR NR
20. Villar et al. [54] Yes Yes Yes NR NR Yes
21. Von der Lippe et al. [55] Yes Yes Yes Yes Yes No
22. Xu et al. [56] Yes Yes Yes Yes Yes Yes
23. Zhang et al. [57] Yes Yes Yes Yes NR Yes